These findings led the authors to conclude that obesity-associated increases in leptin resulted in more PD-1 target being expressed on CD8+ TILs, which in turn led to enhanced anti-PD-1 efficacy. Here, PDCD1 is linked to obesity due to melanocortin 4 receptor deficiency.